Roadzen, Inc. (NASDAQ:RDZN - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,030,000 shares, a growth of 72.0% from the December 15th total of 598,900 shares. Approximately 6.2% of the company's stock are sold short. Based on an average daily trading volume, of 499,000 shares, the short-interest ratio is presently 2.1 days.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the company. Maxim Group decreased their price target on Roadzen from $7.00 to $4.00 and set a "buy" rating for the company in a research note on Friday, November 15th. ThinkEquity assumed coverage on shares of Roadzen in a report on Monday, October 28th. They set a "buy" rating and a $6.00 price target on the stock.
Read Our Latest Research Report on RDZN
Hedge Funds Weigh In On Roadzen
A number of hedge funds have recently made changes to their positions in RDZN. JPMorgan Chase & Co. lifted its holdings in shares of Roadzen by 124.5% in the third quarter. JPMorgan Chase & Co. now owns 28,108 shares of the company's stock worth $33,000 after buying an additional 15,588 shares in the last quarter. Rhumbline Advisers purchased a new stake in Roadzen in the 2nd quarter worth $39,000. Bank of New York Mellon Corp purchased a new stake in Roadzen in the 2nd quarter worth $59,000. Geode Capital Management LLC grew its position in shares of Roadzen by 24.3% during the third quarter. Geode Capital Management LLC now owns 221,210 shares of the company's stock valued at $263,000 after purchasing an additional 43,235 shares in the last quarter. Finally, Murchinson Ltd. purchased a new position in shares of Roadzen during the second quarter valued at about $100,000. Institutional investors own 24.73% of the company's stock.
Roadzen Stock Performance
Shares of NASDAQ RDZN traded up $0.08 during midday trading on Wednesday, reaching $1.57. The stock had a trading volume of 168,230 shares, compared to its average volume of 527,928. The company has a market capitalization of $116.48 million, a price-to-earnings ratio of -0.82 and a beta of 0.28. Roadzen has a 12-month low of $0.71 and a 12-month high of $7.17. The stock has a 50-day moving average of $1.57 and a 200-day moving average of $1.54.
Roadzen Company Profile
(
Get Free Report)
Roadzen, Inc, an insurtech company, provides various insurance products in the United States and internationally. It offers insurance as a service platform, including Via, which enables fleets, carmakers, and insurers to inspect a vehicle using computer vision; Global Distribution Network that enables the configuration, customer quote, payment, and administration of any insurance policy with any insurance carrier as the underwriter; xClaim, which enables digital, touchless, and real-time resolution of claims; StrandD, a digital, real-time dispatch, and tracking for roadside assistance and first notice of loss during accident claims; Good Driving that enables insurers and fleets to recognize drivers, train drivers, and build usage based insurance programs; and Drivebuddy AI, which provides driver-assistance capabilities.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Roadzen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roadzen wasn't on the list.
While Roadzen currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.